The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Formulation and delivery issues for monoclonal antibody therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
Techniques in Protein Chemistry
(1993) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(93)80012-n · Cited by 1,298
Monoclonal antibody therapy of cancer
Adams, G. P., & Weiner, L. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1137 · Cited by 1,246
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Arming antibodies: prospects and challenges for immunoconjugates
Wu, A. M., & Senter, P. D. (2005) · Nature Biotechnology · doi:10.1038/nbt1141 · Cited by 1,052
Monoclonal antibody successes in the clinic
Reichert, J. M., Rosensweig, C. J., Faden, L. B., & Dewitz, M. C. (2005) · Nature Biotechnology · doi:10.1038/nbt0905-1073 · Cited by 733
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Robinson, N. E., & Robinson, A. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.944 · Cited by 532
Glycosylation of Recombinant Antibody Therapeutics
Jefferis, R. (2008) · Biotechnology Progress · doi:10.1021/bp040016j · Cited by 526
Ma, J. K.-C., Hikmat, B. Y., Wycoff, K., Vine, N. D., Chargelegue, D., Yu, L., Hein, M. B., & Lehner, T. (1998) · Nature Medicine · doi:10.1038/nm0598-601 · Cited by 505
Identification of multiple sources of charge heterogeneity in a recombinant antibody
Harris, R. J., Kabakoff, B., Macchi, F. D., Shen, F. J., Kwong, M., Andya, J. D., Shire, S. J., Bjork, N., Totpal, K., & Chen, A. B. (2001) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00548-x · Cited by 500
The incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
Human antibodies from transgenic animals.
Lonberg, N. (2005) · Nature Biotechnology · doi:10.1038/nbt1135 · Cited by 434
Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life
Spiekermann, G. M., Finn, P. W., Ward, E. S., Dumont, J., Dickinson, B. L., Blumberg, R. S., & Lencer, W. I. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020400 · Cited by 402
Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro
Hodoniczky, J., Zheng, Y. Z., & James, D. C. (2005) · Biotechnology Progress · doi:10.1021/bp050228w · Cited by 393
Induction and analysis of aggregates in a liquid IgG1-antibody formulation
Mahler, H.-C., Müller, R., Frieβ, W., Delille, A., & Matheus, S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.004 · Cited by 309
CD3-specific antibody-induced active tolerance: from bench to bedside
Chatenoud, L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1000 · Cited by 309
Cleland, J. L., Lam, X., Kendrick, B., Yang, J., Yang, T., Overcashier, D., Brooks, D., Hsu, C., & Carpenter, J. F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200103)90:3<310::aid-jps6>3.0.co;2-r · Cited by 299
Engineered Antibodies with Increased Activity to Recruit Complement
Idusogie, E. E., Wong, P. Y., Presta, L. G., Gazzano-Santoro, H., Totpal, K., Ultsch, M., & Mulkerrin, M. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2571 · Cited by 291
Robinson, N. E., & Robinson, A. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221463198 · Cited by 287
Biodegradable microparticles as controlled release antigen delivery systems.
O’Hagan, D. T., Rahman, D., McGee, J. P., Jeffery, H., Davies, M. C., Williams, P. M., Davis, S. S., & Challacombe, S. (1991) · PubMed Central · Cited by 270
In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS
Huang, L., Lu, J., Wroblewski, V. J., Beals, J. M., & Riggin, R. M. (2005) · Analytical Chemistry · doi:10.1021/ac0494174 · Cited by 266
Chelius, D., Rehder, D. S., & Bondarenko, P. V. (2005) · Analytical Chemistry · doi:10.1021/ac050672d · Cited by 263
Antioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2
Lam, X. M., Yang, J. Y., & Cleland, J. L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970143s · Cited by 263
Robinson, A. B., McKerrow, J. H., & Cary, P. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.66.3.753 · Cited by 261
Prediction of protein deamidation rates from primary and three-dimensional structure
Robinson, N. E., & Robinson, A. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071066498 · Cited by 258
Development of anti-p185HER2 immunoliposomes for cancer therapy.
Park, J. W., Hong, K., Carter, P., Asgari, H., Guo, L. Y., Keller, G. A., Wirth, C., Shalaby, R., Kotts, C., & Wood, W. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1327 · Cited by 258
Future directions of liposome- and immunoliposome-based cancer therapeutics
Park, J. W., Benz, C. C., & Martin, F. J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.009 · Cited by 240
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes
Dinauer, N., Balthasar, S., Weber, C., Kreuter, J., Langer, K., & von Briesen, H. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.038 · Cited by 234
Bitonti, A. J., Dumont, J. A., Low, S. C., Peters, R. T., Kropp, K. E., Palombella, V. J., Stattel, J. M., Lu, Y., Tan, C. A., Song, J. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403235101 · Cited by 233
Structure‐dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides
Robinson, N. E., Robinson, Z. W., Robinson, B. R., Robinson, A. L., Robinson, J. A., Robinson, M. L., & Robinson, A. B. (2004) · The Journal of Peptide Research · doi:10.1111/j.1399-3011.2004.00151.x · Cited by 230
Production of human monoclonal antibody in eggs of chimeric chickens
Zhu, L., van de Lavoir, M.-C., Albanese, J., Beenhouwer, D. O., Cardarelli, P. M., Cuison, S., Deng, D. F., Deshpande, S., Diamond, J. H., Green, L., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1132 · Cited by 222
Balthasar, S., Michaelis, K., Dinauer, N., von Briesen, H., Kreuter, J., & Langer, K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.047 · Cited by 221
Protein–Solvent Interactions in Pharmaceutical Formulations
Arakawa, T., Kita, Y., & Carpenter, J. F. (1991) · Pharmaceutical Research · doi:10.1023/a:1015825027737 · Cited by 220
Drug transport to brain with targeted liposomes
Schnyder, A., & Huwyler, J. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.99 · Cited by 210
Chicken Egg Yolk Antibodies as Therapeutics in Enteric Infectious Disease: A Review
Mine, Y., & Kovacs-Nolan, J. (2002) · Journal of Medicinal Food · doi:10.1089/10966200260398198 · Cited by 206
Chang, L. (., Shepherd, D., Sun, J., Tang, X. (., & Pikal, M. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20363 · Cited by 199
Effect of Moisture on the Stability of a Lyophilized Humanized Monoclonal Antibody Formulation
Breen, E. D., Curley, J. G., Overcashier, D. E., Hsu, C. C., & Shire, S. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1013054431517 · Cited by 196
Wright, A., & Morrison, S. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1087 · Cited by 192
Andya, J. D., Maa, Y.-F., Costantino, H. R., Nguyen, P.-A., Dasovich, N., Sweeney, T. D., Hsu, C. C., & Shire, S. J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018805232453 · Cited by 190
Non-enzymatic hinge region fragmentation of antibodies in solution
Cordoba, A. J., Shyong, B.-J., Breen, D., & Harris, R. J. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.12.033 · Cited by 188
Duddu, S. P., & Dal Monte, P. R. (1997) · Pharmaceutical Research · doi:10.1023/a:1012144810067 · Cited by 173
Crystalline monoclonal antibodies for subcutaneous delivery
Yang, M. X., Shenoy, B., Disttler, M., Patel, R., McGrath, M., Pechenov, S., & Margolin, A. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131899100 · Cited by 172
Costantino, H. R., Andya, J. D., Nguyen, P.-A., Dasovich, N., Sweeney, T. D., Shire, S. J., Hsu, C. C., & Maa, Y.-F. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9800679 · Cited by 167
Andya, J. D., Hsu, C. C., & Shire, S. J. (2003) · AAPS PharmSci · doi:10.1208/ps050210 · Cited by 165
Retrospective Analysis of the Safety of Herceptin® Immunotherapy in Metastatic Breast Cancer
Cook-Bruns, N. (2001) · Oncology · doi:10.1159/000055403 · Cited by 158
Poelstra, K. A., Barekzi, N. A., Rediske, A. M., Felts, A. G., Slunt, J. B., & Grainger, D. W. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10069 · Cited by 158
Monoclonal antibodies, immunogenicity, and associated infusion reactions.
Cheifetz, A. S., & Mayer, L. (2005) · PubMed · Cited by 152
Effect of Excipients on the Stability and Structure of Lyophilized Recombinant Human Growth Hormone
Costantino, H. R., Carrasquillo, K. G., Cordero, R. A., Mumenthaler, M., Hsu, C. C., & Griebenow, K. H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980069t · Cited by 147
Identification of Sites of Degradation in a Therapeutic Monoclonal Antibody by Peptide Mapping
Kroon, D. J., Baldwin-Ferro, A., & Lalan, P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015894409623 · Cited by 145
Lackey, C. A., Press, O. W., Hoffman, A. S., & Stayton, P. S. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010053l · Cited by 142
Heterogeneity of recombinant antibodies: linking structure to function.
Harris, R. (2005) · PubMed · Cited by 141
Cleland, J. L., Johnson, O. L., Putney, S. D., & Jones, A. J. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00051-3 · Cited by 140
Radkiewicz, J. L., Zipse, H., Clarke, S. G., et al. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0026814 · Cited by 139
Morgan, P. E., Sturgess, A. D., & Davies, M. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21130 · Cited by 136
Gekko, K. (1981) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133638 · Cited by 135
Crystal Structure of HEL4, a Soluble, Refoldable Human VH Single Domain with a Germ-line Scaffold
Jespers, L. S., Schön, O., James, L. C., Veprintsev, D. B., & Winter, G. P. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.013 · Cited by 134
A passionate kiss, then run: exocytosis and recycling of IgG by FcRn
Lencer, W. I., & Blumberg, R. S. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.11.004 · Cited by 134
Complement-Mediated Mechanisms in Anti-GD2 Monoclonal Antibody Therapy of Murine Metastatic Cancer
Imai, M., Landen, C., Ohta, R., Cheung, N. V., & Tomlinson, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1894 · Cited by 132
Crandall, W., & Mackner, L. M. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01411.x · Cited by 125
Tian, W., Zhang, C. L., Hou, S., Yu, X., Cui, F. Z., Xu, Q., Sheng, S. L., Cui, H. Z., & Li, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.025 · Cited by 119
Nakamura, T., Peng, K.-W., Vongpunsawad, S., Harvey, M. E., Mizuguchi, H., Hayakawa, T., Cattaneo, R., & Russell, S. J. (2004) · Nature Biotechnology · doi:10.1038/nbt942 · Cited by 118
Horie, K., Horie, N., Abdou, A. M., Yang, J.-O., Yun, S.-S., Chun, H. N., Park, C.-K., Kim, M., & Hatta, H. (2004) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(04)73549-3 · Cited by 117
Single amino acid substitution altering antigen-binding specificity.
Rudikoff, S., Giusti, A. M., Cook, W. D., & Scharff, M. D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.1979 · Cited by 114
Rational Design of Solution Additives for the Prevention of Protein Aggregation
Baynes, B. M., & Trout, B. L. (2004) · Biophysical Journal · doi:10.1529/biophysj.104.042473 · Cited by 112
Moore, J. M. R., Patapoff, T. W., & Cromwell, M. E. M. (1999) · Biochemistry · doi:10.1021/bi9905516 · Cited by 108
Sane, S. U., Wong, R., & Hsu, C. C. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20014 · Cited by 107
Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres
Wang, J., Chua, K. M., & Wang, C. (2003) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2003.08.072 · Cited by 105
Polyurethane coatings release bioactive antibodies to reduce bacterial adhesion
Rojas, I. A., Slunt, J. B., & Grainger, D. W. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00195-9 · Cited by 104
Sibéril, S., de Romeuf, C., Bihoreau, N., Fernandez, N., Meterreau, J.-L., Regenman, A., Nony, E., Gaucher, C., Glacet, A., Jorieux, S., et al. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.10.008 · Cited by 99
Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Rk, G., Chang, A. C., & Siber, G. R. (1998) · PubMed · Cited by 98
Engineering Antibodies for Therapy
Presta, L. G. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378256 · Cited by 94
Robinson, N. E., & Robinson, A. B. (2004) · Journal of Peptide Research · doi:10.1111/j.1399-3011.2004.00148.x · Cited by 92
Stuart, D. D., Kao, G. Y., & Allen, T. M. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700145 · Cited by 92
Baker, M. (2005) · Nature Biotechnology · doi:10.1038/nbt0905-1065 · Cited by 90
Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms
Zhang, W., & Czupryn, M. J. (2002) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00479-x · Cited by 86
Antibodies as therapeutic agents: vive la renaissance!
Stockwin, L., & Holmes, S. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.7.1133 · Cited by 84
Mordenti, J. J. (1999) · Toxicological Sciences · doi:10.1093/toxsci/52.1.101 · Cited by 78
Lavelle, E. C., Yeh, M.-K., Coombes, A. G. A., & Davis, S. S. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00229-1 · Cited by 77
Antibody conjugates with morpholinodoxorubicin and acid cleavable linkers
Mueller, B. M., Wrasidlo, W., & Reisfeld, R. A. (1990) · Bioconjugate Chemistry · doi:10.1021/bc00005a005 · Cited by 69
Evaluation of novel particles as pulmonary delivery systems for insulin in rats
Garcia‐Contreras, L., Morçöl, T., Bell, S. J. D., & Hickey, A. J. (2003) · AAPS PharmSci · doi:10.1208/ps050209 · Cited by 68
A Non-invasive System for Delivering Neural Growth Factors across the Blood-Brain Barrier: A Review
Granholm, A., Albeck, D. S., Bäckman, C. M., Curtis, M., Ebendal, T., Friden, P. M., Henry, M. A., Hoffer, B. J., Kordower, J. H., Rose, G. M., et al. (1998) · Reviews in the Neurosciences · doi:10.1515/revneuro.1998.9.1.31 · Cited by 67
Antioxidants and protein oxidation.
Griffiths, H. R. (2000) · PubMed · Cited by 66
Luzardo-Alvarez, A., Blarer, N., Peter, K., Romero, J. F., Reymond, C., Corradin, G., & Gander, B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.015 · Cited by 59
Chapman, S. A., Gilkerson, K. L., Davin, T. D., et al. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e040 · Cited by 56
Controlled-release and local delivery of therapeutic antibodies
Grainger, D. W. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1029 · Cited by 53
Daugherty, A. L., Cleland, J. L., Duenas, E. T., & Mrsny, R. J. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00065-9 · Cited by 41
Self-citationSmall Molecule Toxins Targeting Tumor Receptors
Dyba, M. D., Tarasova, N. I., & Michejda, C. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384024 · Cited by 41
Corthésy, B. (2003) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201033378020 · Cited by 38
Al‐Abdulla, I., Garnvwa, J., Rawat, S., Smith, D. S., Landon, J., & Nasidi, A. (2003) · Toxicon · doi:10.1016/s0041-0101(03)00170-3 · Cited by 34
Use of hu-IgG-SCID mice to evaluate the in vivo stability of human monoclonal IgG antibodies
Bazin, R., Boucher, G., Monier, G., Chevrier, M., Verrette, S., Broly, H., & Lemieux, R. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90108-2 · Cited by 29
Effects of substitutions of amino acids on the thermal stability of the Fv fragments of antibodies
Yasui, H., Ito, W., & Kurosawa, Y. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01027-7 · Cited by 28
Fragmentation of Therapeutic Human Immunoglobulin Preparations
Page, M., Chan, W. L., Dilger, P., Bentley, M. L., Forsey, T., Longstaff, C., & Thorpe, R. (1995) · Vox Sanguinis · doi:10.1111/j.1423-0410.1995.tb02592.x · Cited by 26
Advances in Monoclonal Antibody Technology: Genetic Engineering of Mice, Cells, and Immunoglobulins
Peterson, N. C. (2005) · ILAR Journal · doi:10.1093/ilar.46.3.314 · Cited by 24
Walsh, S. M., Kokai‐Kun, J. F., Shah, A., & Mond, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045227.16829.37 · Cited by 23
Javed, Q., Swanson, N., Vohra, H. A., Thurston, H., & Gershlick, A. (2002) · Experimental and Molecular Pathology · doi:10.1006/exmp.2002.2450 · Cited by 22
Controlled release of human immunoglobulin G. 1. Release kinetics studies
Wang, C., Kamalesh, S., & Lee, T. J. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803407 · Cited by 15
Cited by
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22276 · Cited by 350
Stephan, M. T., Ponomarev, V., Brentjens, R. J., Chang, A. H., Dobrenkov, K. V., Heller, G., & Sadelain, M. (2007) · Nature Medicine · doi:10.1038/nm1676 · Cited by 299
Factors Affecting the Viscosity in High Concentration Solutions of Different Monoclonal Antibodies
Yadav, S., Shire, S. J., & Kalonia, D. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22190 · Cited by 255
Developments and Challenges for mAb-Based Therapeutics
Goswami, S., Wang, W., Arakawa, T., & Ohtake, S. (2013) · Antibodies · doi:10.3390/antib2030452 · Cited by 144
Metadata
- Authors
- Daugherty, A. L., & Mrsny, R. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 58
- Issue
- 5-6
- Pages
- 686-706
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2015799566
- Cited by
- 351
- References
- 104
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.